Overcoming multiple myeloma drug resistance in the era of cancer ‘omics’-Reference-Cited by-同舟云学术

Overcoming multiple myeloma drug resistance in the era of cancer ‘omics’

Published:2017-06-13 Issue:3 Volume:59 Page:542-561
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Guang Matthew Ho Zhi¹²,McCann Amanda²,Bianchi Giada¹,Zhang Li¹³,Dowling Paul⁴,Bazou Despina⁴,O’Gorman Peter⁴,Anderson Kenneth C.¹

Affiliation:

1. Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;

2. UCD School of Medicine, College of Health and Agricultural Science and UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland;

3. Department of Hematology, West China Hospital, Sichuan University, Chengdu, China;

4. Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1337115

Reference106 articles.

1. Multiple Myeloma

2. Pathogenesis beyond the cancer clone(s) in multiple myeloma

3. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

4. Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms

5. Treatment options for relapsed and refractory multiple myeloma

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening;Analytical Biochemistry;2024-11

2. Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy;Biomolecules;2024-01-09

3. Lipid metabolic vulnerabilities of multiple myeloma;Clinical and Experimental Medicine;2023-08-28

4. Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs;Clinical and Experimental Medicine;2023-07-08

5. Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma;Cancers;2023-01-15